{"id":24662,"date":"2025-11-14T10:16:26","date_gmt":"2025-11-14T02:16:26","guid":{"rendered":"https:\/\/www.hkioc.com.hk\/?p=24662"},"modified":"2025-11-14T12:05:41","modified_gmt":"2025-11-14T04:05:41","slug":"zenocutuzumab%e8%8e%b7fda%e7%aa%81%e7%a0%b4%e6%80%a7%e7%96%97%e6%b3%95%e8%ae%a4%e5%ae%9a%ef%bc%81%e7%94%a8%e4%ba%8e%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6nrg1%e5%9f%ba%e5%9b%a0%e8%9e%8d%e5%90%88%e3%80%81","status":"publish","type":"post","link":"https:\/\/www.hkioc.com.hk\/zh-hans\/zenocutuzumab%e8%8e%b7fda%e7%aa%81%e7%a0%b4%e6%80%a7%e7%96%97%e6%b3%95%e8%ae%a4%e5%ae%9a%ef%bc%81%e7%94%a8%e4%ba%8e%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6nrg1%e5%9f%ba%e5%9b%a0%e8%9e%8d%e5%90%88%e3%80%81\/","title":{"rendered":"Zenocutuzumab\u83b7FDA\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\uff01\u7528\u4e8e\u6cbb\u7597\u643a\u5e26NRG1\u57fa\u56e0\u878d\u5408\u3001\u665a\u671f\u4e14\u65e0\u6cd5\u624b\u672f\u5207\u9664\u6216\u5df2\u8f6c\u79fb\u7684\u80c6\u7ba1\u764c\u6210\u4eba\u60a3\u8005"},"content":{"rendered":"\n

\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u5df2\u6388\u4e88Zenocutuzumab\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\uff0c\u7528\u4e8e\u6cbb\u7597\u643a\u5e26NRG1\u57fa\u56e0\u878d\u5408\u3001\u665a\u671f\u4e14\u65e0\u6cd5\u624b\u672f\u5207\u9664\u6216\u5df2\u8f6c\u79fb\u7684\u80c6\u7ba1\u764c\u6210\u4eba\u60a3\u8005\u3002<\/p>\n\n\n\n

Zenocutuzumab\u662f\u4e00\u79cd\u53cc\u7279\u5f02\u6027\u6297\u4f53\u836f\u7269\uff0c\u80fd\u591f\u540c\u65f6\u963b\u65adHER2\u548cHER3\u7684\u7ed3\u5408\uff0c\u5e76\u963b\u6b62NRG1\u878d\u5408\u86cb\u767d\u4e0eHER3\u7684\u76f8\u4e92\u4f5c\u7528\uff0c\u4ece\u6e90\u5934\u4e0a\u4e2d\u65ad\u8fd9\u4e00\u5f02\u5e38\u4fe1\u53f7\u901a\u8def\uff0c\u4ece\u800c\u6291\u5236\u80bf\u7624\u7684\u751f\u957f\u3002<\/p>\n\n\n\n

\u5bf9\u4e8eNRG1\u9633\u6027\u665a\u671f\u80c6\u7ba1\u764c<\/strong>\u60a3\u8005\u8fd9\u4e00\u7f55\u89c1\u4e14\u4fb5\u88ad\u6027\u5f3a\u3001\u6cbb\u7597\u9009\u62e9\u6781\u5c11<\/strong>\u7684\u7fa4\u4f53\uff0c\u8fd9\u9879\u8ba4\u5b9a\u51f8\u663e\u4e86\u6709\u6548\u6cbb\u7597\u7684\u8feb\u5207\u9700\u6c42\uff0c\u4e5f\u786e\u8ba4\u4e86Zenocutuzumab\u5728\u6ee1\u8db3\u91cd\u5927\u4e34\u5e8a\u672a\u6ee1\u8db3\u9700\u6c42\u65b9\u9762\u7684\u6f5c\u529b\u3002<\/p>\n\n\n\n

*FDA\u7684\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\uff0c\u7528\u4e8e\u52a0\u901f\u5f00\u53d1\u548c\u5ba1\u8bc4\u5728\u4e25\u91cd\u6216\u5371\u53ca\u751f\u547d\u75be\u75c5\u4e2d\u76f8\u8f83\u73b0\u6709\u7597\u6cd5\u6709\u663e\u8457\u6539\u5584\u6f5c\u529b\u7684\u836f\u7269\u3002<\/p>\n\n\n\n

\u6388\u4e88\u4f9d\u636e<\/strong><\/strong><\/p>\n\n\n\n

FDA\u6b64\u6b21\u6388\u4e88Zenocutuzumab\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\uff0c\u57fa\u4e8e2\u671feNRGy\u4e34\u5e8a\u8bd5\u9a8c\uff08\u7f16\u53f7NCT02912949\uff09\u7684\u7ed3\u679c\u3002\u66f4\u65b0\u6570\u636e\u57282025\u5e74AACR-NCI-EORTC\u5206\u5b50\u9776\u70b9\u56fd\u9645\u5b66\u672f\u5927\u4f1a\u4e0a\u516c\u5e03\uff0c\u8fd9\u4e9b\u6570\u636e\u4e5f\u5c06\u6210\u4e3a\u8be5\u836f\u57282026\u5e74\u5411FDA\u9012\u4ea4\u8865\u5145\u751f\u7269\u5236\u54c1\u8bb8\u53ef\u7533\u8bf7\uff08sBLA\uff09\u7684\u4f9d\u636e\u3002<\/p>\n\n\n\n

\u5173\u4e8e<\/strong>eNRGy<\/strong>\u8bd5\u9a8c<\/strong><\/strong><\/p>\n\n\n\n

\u8fd9\u662f\u4e00\u9879\u5168\u7403\u591a\u4e2d\u5fc3\u76841\/2\u671f\u7814\u7a76\uff0c\u65e8\u5728\u8bc4\u4f30Zenocutuzumab\u5728\u665a\u671fNRG1\u9633\u6027\u5b9e\u4f53\u7624\u60a3\u8005\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u80c6\u7ba1\u764c\u3001\u80f0\u817a\u5bfc\u7ba1\u817a\u764c\u548c\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u3002<\/strong><\/strong><\/p>\n\n\n\n

\u5165\u7ec4\u60a3\u8005\u9700\u5e74\u6ee118\u5c81\uff0c\u88ab\u786e\u8bca\u4e3a\u665a\u671f\u6216\u8f6c\u79fb\u6027\u3001\u5e26\u6709NRG1\u57fa\u56e0\u878d\u5408\u7684\u5b9e\u4f53\u7624\uff0c\u4e14\u5df2\u63a5\u53d7\u8fc7\u6807\u51c6\u6cbb\u7597\u6216\u65e0\u6cd5\u63a5\u53d7\u6807\u51c6\u65b9\u6848\uff1bECOG\u4f53\u529b\u8bc4\u5206\u9700\u57280\u81f32\u4e4b\u95f4\uff08\u610f\u5473\u7740\u60a3\u8005\u8eab\u4f53\u72b6\u51b5\u8f83\u597d\uff0c\u751f\u6d3b\u80fd\u81ea\u7406\uff0c\u5927\u591a\u80fd\u8fdb\u884c\u65e5\u5e38\u6d3b\u52a8\uff0c\u9002\u5408\u63a5\u53d7\u7cfb\u7edf\u6027\u6cbb\u7597\uff09\u3002<\/p>\n\n\n\n

\u6240\u6709\u60a3\u8005\u63a5\u53d7Zenocutuzumab 750\u6beb\u514b\u9759\u8109\u8f93\u6ce8\uff08\u6bcf\u4e24\u5468\u4e00\u6b21\uff0c\u6301\u7eed2\u5c0f\u65f6\uff09\u6cbb\u7597\uff0c\u76f4\u81f3\u75be\u75c5\u8fdb\u5c55\u6216\u51fa\u73b0\u4e0d\u53ef\u63a5\u53d7\u7684\u6bd2\u6027\u53cd\u5e94\u3002\u9996\u6b21\u8f93\u6ce8\u9700\u5ef6\u957f\u81f34\u5c0f\u65f6\uff0c\u5e76\u914d\u5408\u4f7f\u7528\u9000\u70e7\u836f\u3001\u6297\u7ec4\u80fa\u836f\u548c\u7cd6\u76ae\u8d28\u6fc0\u7d20\uff0c\u4ee5\u51cf\u5c11\u8f93\u6db2\u76f8\u5173\u53cd\u5e94\uff08IRR\uff09\u3002\u80bf\u7624\u8bc4\u4f30\u6bcf8\u5468\u8fdb\u884c\u4e00\u6b21\u3002<\/p>\n\n\n\n

\u7814\u7a76\u7684\u4e3b\u8981\u7ec8\u70b9\u4e3a\u5ba2\u89c2\u7f13\u89e3\u7387\uff08ORR\uff09\u3002\u6b21\u8981\u7ec8\u70b9\u5305\u62ec\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\uff08DOR\uff09\u3001\u4e34\u5e8a\u83b7\u76ca\u7387\uff08CBR\uff09\u3001\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u53ca\u5b89\u5168\u6027\u3002<\/p>\n\n\n\n

\u60a3\u8005\u7684\u5e73\u5747\u5e74\u9f84\u4e3a57.5\u5c81\uff0823-82\u5c81\uff09\uff0c\u5973\u6027\u536055%\u3002ECOG\u8bc4\u5206\u4e3a0\u7684\u60a3\u8005\u536063%\uff0c\u4e3b\u8981\u75c5\u7076\u4e3a\u809d\u5185\u80c6\u7ba1\u764c\uff0882%\uff09\u3002\u591a\u6570\u60a3\u8005\u4e3a\u2163\u671f\uff0895%\uff09\uff0c82%\u7684\u60a3\u8005\u56e0\u75be\u75c5\u8fdb\u5c55\u505c\u6b62\u6cbb\u7597\u3002<\/p>\n\n\n\n

\u6cbb\u7597\u53f2\u65b9\u9762\uff0c89%\u7684\u60a3\u8005\u63a5\u53d7\u8fc7\u5168\u8eab\u6cbb\u7597\uff0c\u5176\u4e2d\u5305\u62ec\u5316\u7597\uff0884%\uff09\u3001\u514d\u75ab\u6cbb\u7597\uff0816%\uff09\u3001\u6297VEGF\u6cbb\u7597\uff085%\uff09\u4ee5\u53ca\u7ecf\u52a8\u8109\u5316\u7597\u6813\u585e\uff085%\uff09\u3002\u65e2\u5f80\u6cbb\u7597\u7ebf\u6570\u5e73\u5747\u4e3a1\u7ebf\uff08\u8303\u56f40-4\u7ebf\uff09\u3002\u4ece\u786e\u8bca\u8f6c\u79fb\u6027\u75be\u75c5\u5230\u5165\u7ec4\u7684\u5e73\u5747\u65f6\u95f4\u4e3a9.3\u4e2a\u6708\u3002<\/p>\n\n\n\n

2025\u5e74AACR-NCI-EORTC\u5206\u5b50\u9776\u70b9\u56fd\u9645\u5b66\u672f\u5927\u4f1a\u4e0a\u91cd\u70b9\u5c55\u793a\u4e86\u80c6\u7ba1\u764c\u60a3\u8005\u7684\u6570\u636e\u3002\u5171\u670922\u540d\u60a3\u8005\u7eb3\u5165\u5b89\u5168\u6027\u5206\u6790\uff0c\u5176\u4e2d3\u540d\u56e0\u65e2\u5f80\u63a5\u53d7HER3\u9776\u5411\u6cbb\u7597\u6216\u5b58\u5728\u5176\u4ed6\u9a71\u52a8\u57fa\u56e0\u7a81\u53d8\u88ab\u6392\u9664\uff0c\u56e0\u6b64\u6700\u7ec8\u6709\u6548\u6027\u5206\u6790\u5171\u7eb3\u516519\u4eba\u3002<\/p>\n\n\n\n

\u7814\u7a76\u7ed3\u679c<\/strong><\/strong><\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u5ba2\u89c2\u7f13\u89e3\u7387\uff08ORR\uff09\u4e3a37%<\/strong>\uff0c\u610f\u5473\u7740\u670937%\u7684\u60a3\u8005\u80bf\u7624\u663e\u8457\u7f29\u5c0f\u6216\u5b8c\u5168\u6d88\u5931\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u4e34\u5e8a\u83b7\u76ca\u7387\uff08CBR\uff09\u4e3a58%<\/strong>\uff0c\u610f\u5473\u7740\u670958%\u7684\u60a3\u8005\u75c5\u60c5\u51fa\u73b0\u4e86\u660e\u663e\u597d\u8f6c\u6216\u7a33\u5b9a\uff08\u5305\u62ec\u5b8c\u5168\u7f13\u89e3\u3001\u90e8\u5206\u7f13\u89e3\u6216\u75be\u75c5\u7a33\u5b9a\uff09\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u6cbb\u7597\u5e73\u5747\u6301\u7eed\u65f6\u95f4\u4e3a9.2\u4e2a\u6708\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u5e73\u5747\u8d77\u6548\u65f6\u95f4\u4e3a1.9\u4e2a\u6708\u3002<\/strong><\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u5e73\u5747\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\uff08DOR\uff09\u4e3a7.4\u4e2a\u6708<\/strong>\uff0c\u610f\u5473\u7740\u5bf9\u6cbb\u7597\u6709\u53cd\u5e94\u7684\u60a3\u8005\uff0c\u80bf\u7624\u5e73\u5747\u80fd\u88ab\u63a7\u5236\u5927\u7ea67.4\u4e2a\u6708\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u5e73\u5747\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u4e3a9.2\u4e2a\u6708<\/strong>\uff0c\u610f\u5473\u7740\u4e00\u534a\u60a3\u8005\u57289.2\u4e2a\u6708\u5185\u75c5\u60c5\u6ca1\u6709\u6076\u5316\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>6\u4e2a\u6708\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u7387\uff08PFS\u7387\uff09\u4e3a64.7%<\/strong>\uff0c\u610f\u5473\u7740\u63a5\u53d7\u6cbb\u7597\u540e6\u4e2a\u6708\u65f6\uff0c\u670964.7%\u7684\u60a3\u8005\u75c5\u60c5\u6ca1\u6709\u8fdb\u5c55\u6216\u6076\u5316\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>12\u4e2a\u6708\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u7387\uff08PFS\u7387\uff09\u4e3a21.8%<\/strong>\uff0c\u610f\u5473\u7740\u63a5\u53d7\u6cbb\u7597\u540e12\u4e2a\u6708\u65f6\uff0c\u670921.8%\u7684\u60a3\u8005\u75c5\u60c5\u6ca1\u6709\u8fdb\u5c55\u6216\u6076\u5316\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u5728\u5e73\u5747\u968f\u8bbf15.2\u4e2a\u6708\u65f6\uff0c\u5e73\u5747\u603b\u751f\u5b58\u671f\uff08OS\uff09\u5c1a\u672a\u8fbe\u5230<\/strong>\uff0c\u610f\u5473\u7740\u591a\u6570\u60a3\u8005\u4ecd\u7136\u5b58\u6d3b\uff0c\u7597\u6548\u6301\u7eed\u89c2\u5bdf\u4e2d\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>12\u4e2a\u6708\u7684\u603b\u4f53\u751f\u5b58\u7387\u4e3a80.5%<\/strong>\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>18\u4e2a\u6708\u7684\u603b\u4f53\u751f\u5b58\u7387\u4e3a67.1%<\/strong>\u3002<\/p>\n\n\n\n

\u27a4<\/strong>\u5728\u53ef\u8bc4\u4f30CA19-9<\/strong>\uff08\u764c\u6297\u539f19-9\uff0c\u4e00\u79cd\u7cd6\u7c7b\u80bf\u7624\u6807\u5fd7\u7269\uff09\u6307\u6807\u7684\u60a3\u8005\u4e2d\uff08\u517116\u540d\uff09\uff1a<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u6240\u6709\u60a3\u8005\u7684\u8840\u6e05\u6c34\u5e73\u5747\u4e0b\u964d\uff0c\u610f\u5473\u7740\u80bf\u7624\u6807\u5fd7\u7269CA19-9\u7684\u6d53\u5ea6\u666e\u904d\u964d\u4f4e\u3002<\/strong><\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u5176\u4e2d68.8%\uff0811\u4eba\uff09\u7684\u60a3\u8005\u8840\u6e05\u6c34\u5e73\u964d\u4f4e\u8d85\u8fc750%\uff0c\u5e76\u4e14\u8fd9\u79cd\u6539\u5584\u5728\u6cbb\u7597\u4ec51\u4e2a\u6708\u540e\u5c31\u51fa\u73b0<\/strong>\uff0c\u8bf4\u660e\u836f\u7269\u8d77\u6548\u8fc5\u901f\u3001\u6291\u7624\u6548\u679c\u663e\u8457\u3002<\/p>\n\n\n\n

\u27a4<\/strong>\u5728\u53ef\u8bc4\u4f30CEA<\/strong>\uff08\u764c\u80da\u6297\u539f\uff0c\u4e00\u79cd\u5e38\u7528\u7684\u80bf\u7624\u6807\u5fd7\u7269\uff09\u6307\u6807\u7684\u60a3\u8005\u4e2d\uff08\u517111\u540d\uff09\uff1a<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>63.6%\uff087\u4eba\uff09\u7684\u60a3\u8005\u8840\u6e05\u6c34\u5e73\u964d\u4f4e\u8d85\u8fc750%\uff0c\u4e5f\u662f\u57281\u4e2a\u6708\u540e\u5c31\u51fa\u73b0<\/strong>\u3002<\/p>\n\n\n\n

\u5b89\u5168\u6027<\/strong><\/strong><\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u5b89\u5168\u6027\u65b9\u9762\uff0c\u4e0e\u6574\u4e2aeNRGy\u7814\u7a76\u4eba\u7fa4\u4e00\u81f4\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u5927\u591a\u6570\u6cbb\u7597\u76f8\u5173\u4e0d\u826f\u4e8b\u4ef6\u4e3a\u8f7b\u4e2d\u5ea6\uff081-2\u7ea7\uff09<\/strong>\uff0c\u5305\u62ec\uff1a\u8d2b\u8840\uff0845%\uff0c\u5176\u4e2d\u4e25\u91cd\u76843-4\u7ea714%\uff09\uff0c\u8179\u6cfb\uff0841%\uff0c\u65e03-4\u7ea7\uff09\uff0c\u4f4e\u9541\u8840\u75c7\uff0827%\uff0c3-4\u7ea79%\uff09\uff0c\u8179\u75db\uff0827%\uff0c3-4\u7ea75%\uff09\uff0c\u54b3\u55fd\u3001\u75b2\u52b3\u3001\u6076\u5fc3\uff08\u540427%\uff0c\u5747\u4e3a\u8f7b\u5ea6\uff09\uff0c\u8c37\u4e19\u8f6c\u6c28\u9176\u5347\u9ad8\uff0823%\uff0c3-4\u7ea75%\uff09\u7b49\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>5\u540d\u60a3\u8005\uff0823%\uff09\u51fa\u73b0\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\uff0c\u4f46\u5747\u4e0e\u836f\u7269\u65e0\u5173\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>\u65e0\u56e0\u6bd2\u6027\u505c\u836f\u62165\u7ea7\u4e0d\u826f\u4e8b\u4ef6\uff08\u6b7b\u4ea1\uff09\u3002<\/p>\n\n\n\n

\u2022<\/strong> <\/strong>1\u540d\u60a3\u8005\u51fa\u73b03\u7ea7\u4ee5\u4e0a\u8d2b\u8840\uff0c2\u540d\u60a3\u8005\u51fa\u73b0\u8f7b\u5ea6\u8f93\u6db2\u53cd\u5e94\uff081-2\u7ea7\uff09\u3002<\/strong><\/p>\n\n\n\n

\u4e13\u5bb6\u8bc4\u8bba<\/strong><\/strong><\/p>\n\n\n\n

NRG1\u878d\u5408\u867d\u7136\u7f55\u89c1\uff0c\u4f46\u5728\u80c6\u7ba1\u764c\u4e2d\u662f\u4e00\u4e2a\u53ef\u88ab\u7cbe\u51c6\u9776\u5411\u7684\u9a71\u52a8\u57fa\u56e0\u3002\u57282024\u5e7412\u6708\uff0cZenocutuzumab\u5df2\u83b7\u5f97FDA\u52a0\u901f\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u643a\u5e26NRG1\u878d\u5408\u7684\u665a\u671f\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u548c\u80f0\u817a\u817a\u764c\u60a3\u8005\u3002\u6b64\u6b21eNRGy\u8bd5\u9a8c\u7684\u65b0\u6570\u636e\u663e\u793a\uff0c\u8be5\u836f\u4e5f\u6709\u671b\u6210\u4e3aNRG1\u878d\u5408\u9633\u6027\u80c6\u7ba1\u764c\u60a3\u8005\u7684\u91cd\u8981\u6cbb\u7597\u9009\u62e9\u3002<\/p>\n\n\n\n

Z<\/strong>enocutuzumab<\/strong>\u5df2\u83b7\u6279\u9002\u5e94\u75c7<\/strong><\/strong><\/p>\n\n\n\n

2024\u5e7412\u67084\u65e5\uff0c\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u52a0\u901f\u6279\u51c6Zenocutuzumab\uff0c\u9002\u7528\u4e8e\u63a5\u53d7\u8fc7\u7cfb\u7edf\u6cbb\u7597\u540e\uff0c\u643a\u5e26NRG1\u57fa\u56e0\u878d\u5408\u7684\u665a\u671f\u4e0d\u53ef\u5207\u9664\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u6216\u80f0\u817a\u817a\u764c\u6210\u4eba\u60a3\u8005\u3002<\/strong><\/p>\n\n\n\n

Zenocutuzumab\u7684\u52a0\u901f\u6279\u51c6\u57fa\u4e8e\u5ba2\u89c2\u7f13\u89e3\u7387\uff08ORR\uff09\u548c\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\uff08DOR\uff09\u6570\u636e\uff1b\u6301\u7eed\u6279\u51c6\u9700\u57fa\u4e8e\u540e\u7eed\u786e\u8ba4\u6027\u7814\u7a76\u7ed3\u679c\uff0c\u8fdb\u4e00\u6b65\u786e\u8ba4\u60a3\u8005\u7684\u4e34\u5e8a\u83b7\u76ca\u3002<\/p>\n\n\n\n

\u8d44\u6599\u6765\u6e90\uff1a
[1]https:\/\/www.onclive.com\/view\/fda-grants-fast-track-designation-to-zenocutuzumab-in-nrg1-cholangiocarcinoma
[2]https:\/\/www.partnertx.com\/zenocutuzumab-zbco-granted-fda-breakthrough-therapy-designation-for-nrg1-cholangiocarcinoma-data-highlighting-potential-of-zenocutuzumab-zbco-in-nrg1-cholangiocarcinoma-to-be-presented-at-aacr-nci\/<\/p>\n\n\n\n

\u8f6c\u8f7d\u8bf7\u8054\u7cfb\u6388\u6743\uff0c\u6216\u6ce8\u660e\u6765\u6e90\u3002<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u5df2\u6388\u4e88Zenocutuzumab\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\uff0c\u7528\u4e8e\u6cbb\u7597\u643a\u5e26NRG1\u57fa\u56e0\u878d\u5408\u3001<\/p>\n","protected":false},"author":14,"featured_media":24663,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6650],"tags":[],"yst_prominent_words":[],"class_list":["post-24662","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-holangiocarcinoma-zh-hans"],"_links":{"self":[{"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/posts\/24662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/comments?post=24662"}],"version-history":[{"count":3,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/posts\/24662\/revisions"}],"predecessor-version":[{"id":24728,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/posts\/24662\/revisions\/24728"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/media\/24663"}],"wp:attachment":[{"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/media?parent=24662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/categories?post=24662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/tags?post=24662"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/yst_prominent_words?post=24662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}